Prehospital Academy Lesson 15.3
Respiratory Emergencies: Diseases of the Lower Airway (Obstructive)
This lesson delves into obstructive diseases of the lower airway, a significant category of respiratory emergencies encountered by EMTs. Unlike upper airway obstructions, which often involve mechanical blockage, lower airway obstructive diseases are characterized by narrowing of the bronchi and bronchioles, trapping air and impairing efficient gas exchange. Understanding the pathophysiology and presentation of these conditions is crucial for effective prehospital assessment and management.
Lower Airway Overview and Obstructive Challenges
The lower airway, beginning below the larynx, includes the trachea, bronchi, bronchioles, and alveoli. In obstructive lung diseases, the primary issue is resistance to airflow, especially during exhalation, due to narrowing of the airways. This leads to air trapping, increased work of breathing, and ultimately, impaired gas exchange and hypoxia.
EMTs must be adept at recognizing the signs of lower airway obstruction and implementing appropriate interventions to improve airflow and oxygenation.
Pulmonary Edema
Pulmonary edema is a condition characterized by fluid accumulation in the alveoli and interstitial spaces of the lungs. While not strictly an obstructive disease, it often presents with significant respiratory distress and can lead to severe hypoxia.
Pathophysiology: Typically related to cardiac dysfunction (e.g., congestive heart failure) where the heart's inability to pump effectively causes blood to back up into the pulmonary circulation, increasing pressure and forcing fluid into the lung tissue.
Signs and Symptoms: Dyspnea (shortness of breath), orthopnea (difficulty breathing when lying flat), paroxysmal nocturnal dyspnea (sudden shortness of breath at night), crackles (rales) on auscultation, frothy sputum (pink-tinged in severe cases), anxiety, cyanosis.
Management: High-flow oxygen, ventilatory support (CPAP if available and indicated), positioning (sitting upright), and rapid transport.
Chronic Obstructive Pulmonary Disease (COPD)
COPD is a progressive lung disease characterized by long-term poor airflow. It is often a combination of emphysema and chronic bronchitis, primarily caused by long-term exposure to irritants, most commonly cigarette smoke.
Emphysema
Pathophysiology: Destruction of the alveolar walls and capillaries, leading to an enlargement of the air sacs and a decrease in the surface area for gas exchange. This results in air trapping and reduced elastic recoil of the lungs.
Signs and Symptoms: "Pink puffers" – typically thin, barrel chest, prolonged exhalation through pursed lips, minimal cough, often alert but dyspneic.
Chronic Bronchitis
Pathophysiology: Chronic inflammation and excessive mucus production in the bronchi, leading to narrowing of the airways and a persistent cough.
Signs and Symptoms: "Blue bloaters" – typically overweight, chronic productive cough, cyanosis, peripheral edema (due to right-sided heart failure), often wheezing and rhonchi.
General COPD Management:
Assessment: Assess for signs of respiratory distress, oxygen saturation, and accessory muscle use. Obtain a thorough history regarding smoking and previous exacerbations.
Interventions: Administer oxygen cautiously to achieve target SpO2 (often 88-92% for chronic CO2 retainers), assist with prescribed bronchodilators (metered-dose inhaler or small-volume nebulizer), ventilatory support as needed. Encourage a position of comfort.
Asthma
Asthma is a chronic inflammatory disease of the airways that causes reversible episodes of bronchoconstriction, increased mucus production, and airway edema. Triggers can include allergens, exercise, cold air, or respiratory infections.
Pathophysiology: Bronchospasm (constriction of the smooth muscles surrounding the bronchioles), airway inflammation, and increased mucus production combine to narrow the airways.
Signs and Symptoms: Dyspnea, wheezing (especially on exhalation), cough, chest tightness, tachypnea, tachycardia, use of accessory muscles, pulsus paradoxus (drop in systolic blood pressure during inspiration in severe cases). "Silent chest" indicates severe obstruction.
Management: Administer high-flow oxygen, assist with prescribed bronchodilators (e.g., albuterol), encourage a position of comfort, and consider rapid transport for severe attacks.
Critical Thinking Questions
You are treating a patient experiencing severe dyspnea, orthopnea, and frothy pink sputum. Based on these findings, what is your suspected diagnosis, and how does its pathophysiology differ from that of an acute asthma attack?
Compare and contrast the typical presentations of "pink puffers" (emphysema) and "blue bloaters" (chronic bronchitis), explaining the physiological reasons behind their distinguishing characteristics.
A patient with known asthma is found with a "silent chest" despite significant respiratory effort. What does this assessment finding indicate about the severity of their condition, and what immediate interventions are necessary?
Explain why cautious oxygen administration is often recommended for some COPD patients. What are the potential risks of over-oxygenation in these individuals?
You respond to a 45-year-old patient in moderate respiratory distress who is using a prescribed bronchodilator. After several doses, their condition is not improving. What additional assessment findings would prompt you to consider initiating CPAP, if available, or pursuing more aggressive ventilatory support?